In addition, our study showed that silencing of FLCN enhanced the expression of the HIF2α protein and implicated a novel molecular mechanism that FLCN interacted with HIF2α and impacted ccRCC physiological activity. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.